Programme | Speaker |
|---|---|
Welcome and Introduction | Chairperson: Henning Hermanns |
FXa Inhibitor Bleeding: Where Are We Now? | Oliver Grottke |
Using Factor Concentrates Wisely in Cardiac Surgery | Keyvan Karkouti |
Different Patients, Different Bleeds: Case Discussion | Felix Schmitt |
Panel discussion and Q&A |
Belgium06/06/2026
From Evidence to Action: Managing Complex Bleeding in the Real World
Octapharma Symposium at Euroanaesthesia 2026
:quality(80))
Introduction
The symposium will focus on the evolving management of complex bleeding in real-world clinical practice, highlighting the translation of emerging evidence into practical decision-making. Key themes will include the optimal management of FXa inhibitor–associated bleeding, particularly the comparative role of reversal strategies and prothrombin complex concentrates in the context of changing evidence and guideline landscapes. The discussion will also explore the rational and cost-conscious use of factor concentrates in cardiac surgery, especially in environments where advanced coagulation monitoring may not be available.
Across these areas, the overarching emphasis will be on individualized patient assessment, balancing efficacy, safety, and resource considerations to improve outcomes in diverse and complex bleeding scenarios.
Symposium programme
Saturday, June 6 at 12:00 CET
Meet the speakers
Oliver Grottke
Department of Anaesthesiology, RWTH-Aachen University Hospital, Aachen, Germany.
Keyvan Karkouti
Department of Anaesthesia and Pain Management, University Health Network, Sinai Health System, Women’s College Hospital, Toronto, Canada.
Felix Schmitt
Senior Consultant and Deputy Medical Director, Department of Anaesthesiology, Heidelberg University Hospital. Germany.
Join live on Science Hub
This symposium will be live-streamed directly from Rotterdam on Saturday, June 6 at 12:00 CET.
The event is for healthcare professional only.